These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12856053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P.
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F, Sadeghinia A.
    Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
    [Abstract] [Full Text] [Related]

  • 4. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A, Stipić T, Skerlev M, Basta-Juzbasić A.
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [Abstract] [Full Text] [Related]

  • 5. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA, Murphy AG, Olliaro P, Croft SL.
    Trans R Soc Trop Med Hyg; 1994 Nov; 88(2):223-5. PubMed ID: 8036682
    [Abstract] [Full Text] [Related]

  • 6. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA, Mendoza CE, Rizzo NR, Kroeger A.
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [Abstract] [Full Text] [Related]

  • 7. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.
    Bryceson AD, Murphy A, Moody AH.
    Trans R Soc Trop Med Hyg; 1994 Nov; 88(2):226-8. PubMed ID: 8036683
    [Abstract] [Full Text] [Related]

  • 8. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Nov; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
    Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R.
    Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 11. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P.
    Trans R Soc Trop Med Hyg; 1997 Jul; 91(4):473-5. PubMed ID: 9373659
    [Abstract] [Full Text] [Related]

  • 12. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 13. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 14. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J, Halevy S, Grunwald MH, Weinrauch L.
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic trial in experimental tegumentary leishmaniasis caused by Leishmania (Leishmania) amazonensis. A comparative study between mefloquine and aminosidine.
    Galvão LO, Moreira Júnior S, Medeiros Júnior P, Lemos GJ, Cunha NF, Antonino RM, Santos Filho BS, Magalhães AV.
    Rev Soc Bras Med Trop; 2000 Aug; 33(4):377-82. PubMed ID: 10936952
    [Abstract] [Full Text] [Related]

  • 16. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom.
    Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GM, Olliaro P, Bryceson AD.
    Trans R Soc Trop Med Hyg; 1992 Aug; 86(6):617-9. PubMed ID: 1287915
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ, Tareen AK, Khursheed T, Darr N.
    J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 19. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A, Davami M.
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [Abstract] [Full Text] [Related]

  • 20. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.
    el-Safi SH, Murphy AG, Bryceson AD, Neal RA.
    Trans R Soc Trop Med Hyg; 1990 Sep; 84(5):690-1. PubMed ID: 2278070
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.